Clinical utility of the protein S100B to evaluate traumatic brain injury in the presence of acute alcohol intoxication

Journal of Head Trauma Rehabilitation

Volumn 27, Issue 2, 2012, Pages 123-134

  Lange, Rael T ^a,b   Iverson, Grant L ^b,c   Brubacher, Jeffrey R ^b  

^a Defense and Veterans Brain Injury Center   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BC Mental Health & Addiction Services   (Canada)

Author keywords

alcohol; biomarker; S100B; traumatic brain injury

Indexed keywords

BIOLOGICAL MARKER; PROTEIN S100B;

ACUTE ALCOHOL INTOXICATION; ADULT; ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ARTICLE; BLOOD SAMPLING; CANADA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HYPOTHESIS; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; TRAUMATIC BRAIN INJURY; URBAN AREA;

ADULT; ALCOHOLIC INTOXICATION; BIOLOGICAL MARKERS; BRAIN INJURIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; S100 PROTEINS;

EID: 84858131936     PISSN: 08859701     EISSN: 1550509X     Source Type: Journal    
DOI: 10.1097/HTR.0b013e31820e6840     Document Type: Article

References (43)

1. Kochanek PM, Berger RP, Bayir H,Wagner AK, Jenkins LW, Clark RS. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr Opin Crit Care. 2008;14(2):135-141. (Pubitemid 351498777)
2. Ingebrigtsen T, Romner B. Biochemical serum markers for brain damage: a short review with emphasis on clinical utility in mild head injury. Restor Neurol Neurosci. 2003;21(3-4):171-176. (Pubitemid 37330257)
3. Buki A, Kövesdi E, Pál J, Czeiter E. Clinical and model research of neurotrauma. MethodsMol Biol. 2009;566:41-55.
4. de Kruijk JR, Leffers P, Menheere PP, Meerhoff S, Twijnstra A. S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls. Acta Neurol Scand. 2001;103(3):175-179. (Pubitemid 32158440)
5. Biberthaler P, Mussack T, Wiedemann E, et al. Evaluation of S-100b as a specific marker for neuronal damage due to minor head trauma. World J Surg. 2001;25(1):93-97. (Pubitemid 32422226)
6. Nygren De Boussard C, Fredman P, Lundin A, Andersson K, Edman G, Borg J. S100 in mild traumatic brain injury. Brain Inj. 2004;18(7):671-683. (Pubitemid 38735473)
7. Muller K, Townend W, Biasca N, et al. S100B serum level predicts computed tomography findings after minor head injury. J Trauma. 2007;62(6):1452-1456. (Pubitemid 46918752)
8. Unden J, Romner B. Can low serum levels of S100B predict normal CT findings after minor head injury in adults?: an evidence-based review and meta-analysis. J Head Trauma Rehabil. 2010;25(4):228-240.
9. Herrmann M, Curio N, Jost S, Wunderlich MT, Synowitz H, Wallesch CW. Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury. Restor Neurol Neurosci. 1999;14(2-3):109-114. (Pubitemid 29173191)
10. Herrmann M, Curio N, Jost S, et al. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. J Neurol Neurosurg Psychiatry. 2001;70(1):95-100. (Pubitemid 32096128)
11. Wiesmann M, Steinmeier E, Magerkurth O, Linn J, Gottmann D, Missler U. Outcome prediction in traumatic brain injury: comparison of neurological status, CT findings, and blood levels of S100B and GFAP. Acta Neurol Scand. 2010;121(3):178-185.
12. Townend WJ, Guy MJ, Pani MA, Martin B, Yates DW. Head injury outcome prediction in the emergency department: a role for protein S-100B? JNeurolNeurosurg Psychiatry. 2002;73(5):542-546. (Pubitemid 35246808)
13. Nylen K, Ost M, Csajbok LZ, et al. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury. Acta Neurochir (Wien). 2008;150(3):221-227; discussion 227.
14. Stranjalis G, Korfias S, Papapetrou C, et al. Elevated serum S-100B protein as a predictor of failure to short-term return to work or activities after mild head injury. J Neurotrauma. 2004;21(8):1070-1075. (Pubitemid 39096857)
15. Bechtel K, Frasure S, Marshall C, Dziura J, Simpson C. Relationship of serum S100B levels and intracranial injury in children with closed head trauma. Pediatrics. 2009;124(4):e697-704.
16. Geyer C, Ulrich A, Gräfe G, Stach B, Till H. Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury. J Neurosurg Pediatr. 2009;4(4):339-344.
17. Stapert S, de Kruijk J, Houx P, Menheere P, Twijnstra A, Jolles J. S-100B concentration is not related to neurocognitive performance in the first month after mild traumatic brain injury. Eur Neurol. 2005;53(1):22-26. (Pubitemid 40522827)
18. de Boussard CN, Lundin A, Karlstedt D, Edman G, Bartfai A, Borg J. S100 and cognitive impairment after mild traumatic brain injury. J RehabilMed. 2005;37(1):53-57.
19. Stalnacke BM, Björnstig U, Karlsson K, Sojka P. One-year follow-up of mild traumatic brain injury: postconcussion symptoms, disabilities, and life satisfaction in relation to serum levels of S-100B and neurone-specific enolase in acute phase. J Rehabil Med. 2005;37(5):300-305. (Pubitemid 41341635)
20. Cowie SE, Brubacher JR, Lee D, Lee SK, Simons R. Documentation of substance problems in Canadian trauma patients. Presented at the Canadian Trauma Scientific Meeting; June 2005; Whistler, BC, Canada.
21. Canadian Institute for Health Information, Ontario Trauma Registry Bulletin: Alcohol-Related Major Injury Hospital Hospitalizations in Ontario, 2000/2001. Toronto, Ontario, Canada: Canadian Institute for Health Information; 2002.
22. Miller N. Alcohol and drug disorders. In: Silver JM, Yudofsky SC, Hales RE, eds. Neuropsychiatry of Traumatic Brain Injury. Washington, DC: American Psychiatric Press, Inc; 1994:471-512.
23. Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A,Manley GT;Workshop Scientific Team and Advisory Panel Members. Classification of traumatic brain injury for targeted therapies. J Neurotrauma. 2008;25(7):719-738.
24. Alexander S, Kerr ME, Yonas H, Marion DW. The effects of admission alcohol level on cerebral blood flow and outcomes after severe traumatic brain injury. J Neurotrauma. 2004;21(5): 575-583. (Pubitemid 38656754)
25. Shih HC, Hu SC, Yang CC, Ko TJ, Wu JK, Lee CH. Alcohol intoxication increases morbidity in drivers involved in motor vehicle accidents. Am J Emerg Med. 2003;21(2):91-94. (Pubitemid 36396816)
26. Sperry JL, Gentilello LM, Minei JP, Diaz-Arrastia RR, Friese RS, Shafi S.Waiting for the patient to "sober up:" effect of alcohol intoxication on Glasgow coma scale score of brain injured patients. J Trauma. 2006;61(6):1305-1311. (Pubitemid 44973291)
27. Stuke L, Diaz-Arrastia R, Gentilello LM, Shafi S. Effect of alcohol on Glasgow Coma Scale in head-injured patients. Ann Surg. 2007;245(4):651-655. (Pubitemid 46555671)
28. Lange RT, Iverson GL, Brubacher JR, Franzen MD. Effect of blood alcohol level on Glasgow Coma Scale scores following traumatic brain injury. Brain Inj. 2010;24(7-8):919-927.
29. Biberthaler P, Mussack T, Wiedemann E, et al. Influence of alcohol exposure on S-100b serum levels. Acta Neurochir Suppl. 2000;76:177-179.
30. Biberthaler P, Mussack T, Wiedemann E, et al. Elevated serum levels of S-100B reflect the extent of brain injury in alcohol intoxicated patients after mild head trauma. Shock. 2001;16(2):97-101. (Pubitemid 33596741)
31. Enochsson L, Carlsson-Sanz S, van der Linden J. The influence of alcohol and time on the S-100B levels of patients with minor head injury. Eur J Neurol. 2005;12(6):445-448. (Pubitemid 40768663)
32. Mussack T, Biberthaler P, Kanz KG, et al. Immediate S-100B and neuron-specific enolase plasma measurements for rapid evaluation of primary brain damage in alcohol-intoxicated, minor headinjured patients. Shock. 2002;18(5):395-400.
33. Lange RT, Brubacher JR, Iverson GL, Procyshyn RM, Mitrovic S. Differential effects of alcohol intoxication on S100B levels following traumatic brain injury. J Trauma. 2010;68(5):1065-1071.
34. Williams DH, Levin HS, Eisenberg HM. Mild head injury classification. Neurosurgery. 1990;27(3):422-428. (Pubitemid 20294100)
35. Cohen J. Statistical PowerAnalysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
36. Curtis KL, Greve KW, Bianchini KJ, Brennan A. California verbal learning test indicators of malingered neurocognitive dysfunction: sensitivity and specificity in traumatic brain injury. Assessment. 2006;13(1):46-61. (Pubitemid 43812614)
37. Heinly MT, Greve KW, Bianchini KJ, Love JM, Brennan A.WAIS digit span-based indicators of malingered neurocognitive dysfunction: classification accuracy in traumatic brain injury. Assessment. 2005;12(4):429-444. (Pubitemid 41703612)
38. Slick D. Psychometrics in neuropsychological assessment. In: Strauss E, Sherman EMS, Spreen O, eds. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford University Press; 2006:3-43.
39. Greve KW, Bianchini KJ, Love JM, Brennan A, Heinly MT. Sensitivity and specificity of MMPI-2 validity scales and indicators to malingered neurocognitive dysfunction in traumatic brain injury. Clin Neuropsychol. 2006;20(3):491-512. (Pubitemid 44221702)
40. Morochovic R, Rácz O, Kitka M, et al. Serum S100B protein in early management of patients after mild traumatic brain injury. Eur J Neurol. 2009;16(10):1112-1117.
41. Corrigan JD, Bogner JA, Mysiw WJ, Clinchot D, Fugate L. Systematic bias in outcome studies of persons with traumatic brain injury. Arch PhysMed Rehabil. 1997;78(2):132-137. (Pubitemid 27078671)
42. Corrigan JD, Harrison-Felix C, Bogner J, Dijkers M, Terrill MS, Whiteneck G. Systematic bias in traumatic brain injury outcome studies because of loss to follow up. Arch Phys Med Rehabil. 2003;84(2):153-160. (Pubitemid 36176753)
43. Lo TY, Jones PA, Minns RA. Pediatric brain trauma outcome prediction using paired serum levels of inflammatory mediators and brain-specific proteins. J Neurotrauma. 2009;26(9):1479-1487.